Fischetti Gary P

Director

Anika Therapeutics, Inc.

US, Bedford [HQ]

CIK 1929510

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

27,449

Price per Share :

$16.19

Equivalence :

$444,399.31

A

Form 4

27,449 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 07/09/24
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025.
A

Form 4

21,678 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/14/23
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.
A

Form 4

15,178 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 04/13/23
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on April 13, 2024.